Maxigen Biotech Stock Number Of Employees
| 1783 Stock | TWD 42.90 0.10 0.23% |
Maxigen Biotech fundamentals help investors to digest information that contributes to Maxigen Biotech's financial success or failures. It also enables traders to predict the movement of Maxigen Stock. The fundamental analysis module provides a way to measure Maxigen Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Maxigen Biotech stock.
Maxigen |
Maxigen Biotech Company Number Of Employees Analysis
Maxigen Biotech's Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Current Maxigen Biotech Number Of Employees | 20 |
Most of Maxigen Biotech's fundamental indicators, such as Number Of Employees, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Maxigen Biotech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
| Competition |
Based on the recorded statements, Maxigen Biotech is currently employing 20.0 people. This is 99.82% lower than that of the Healthcare sector and 99.94% lower than that of the Drug Manufacturers - Major industry. The number of employees for all Taiwan stocks is 99.89% higher than that of the company.
Maxigen Number Of Employees Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Maxigen Biotech's direct or indirect competition against its Number Of Employees to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Maxigen Biotech could also be used in its relative valuation, which is a method of valuing Maxigen Biotech by comparing valuation metrics of similar companies.Maxigen Biotech is currently under evaluation in number of employees category among related companies.
Maxigen Fundamentals
| Return On Equity | 0.0926 | |||
| Return On Asset | 0.0454 | |||
| Profit Margin | 0.19 % | |||
| Operating Margin | 0.16 % | |||
| Current Valuation | 3.32 B | |||
| Shares Outstanding | 84.7 M | |||
| Shares Owned By Insiders | 51.89 % | |||
| Shares Owned By Institutions | 2.28 % | |||
| Price To Earning | 33.55 X | |||
| Price To Book | 3.24 X | |||
| Price To Sales | 6.63 X | |||
| Revenue | 511.98 M | |||
| Gross Profit | 261.03 M | |||
| EBITDA | 130.56 M | |||
| Net Income | 87.67 M | |||
| Cash And Equivalents | 390.34 M | |||
| Cash Per Share | 5.62 X | |||
| Total Debt | 16.62 M | |||
| Debt To Equity | 1.50 % | |||
| Current Ratio | 7.81 X | |||
| Book Value Per Share | 14.75 X | |||
| Cash Flow From Operations | 117.59 M | |||
| Earnings Per Share | 1.23 X | |||
| Number Of Employees | 20 | |||
| Beta | 1.05 | |||
| Market Capitalization | 5.02 B | |||
| Total Asset | 1.27 B | |||
| Retained Earnings | (14 M) | |||
| Working Capital | 560 M | |||
| Current Asset | 623 M | |||
| Current Liabilities | 63 M | |||
| Annual Yield | 0.02 % | |||
| Net Asset | 1.27 B |
About Maxigen Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Maxigen Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Maxigen Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Maxigen Biotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Maxigen Biotech. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Complementary Tools for Maxigen Stock analysis
When running Maxigen Biotech's price analysis, check to measure Maxigen Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Maxigen Biotech is operating at the current time. Most of Maxigen Biotech's value examination focuses on studying past and present price action to predict the probability of Maxigen Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Maxigen Biotech's price. Additionally, you may evaluate how the addition of Maxigen Biotech to your portfolios can decrease your overall portfolio volatility.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |